Dellann Elliott Mydland on Testing Brain Tumor Tissue

Article

Dellann Elliott Mydland, from the Chris Elliott Fund, discusses the importance of testing brain tumor tissue before surgery.

Dellann Elliott Mydland, from the Chris Elliott Fund, discusses the importance of testing brain tumor tissue before surgery.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Photo of a woman with blonde hair wearing a denim jacket in front of a blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Related Content
Graphic image of a blue brain on a blue background

Breakthrough Designation Granted to BCB-276 for Pediatric DIPG

Chris Ryan
April 25th 2025
Article

Findings from the phase 1 BrainChild-03 trial support breakthrough designation for BCB-276 for pediatric diffuse intrinsic pontine glioma.

The Vitals

Jacki Garcia and Kristin Hendrickson on Navigating Patients Through Phase 0 Trials

Lindsay Fischer
July 15th 2023
Podcast

Jacki Garcia, RN, BSN, CNRN; and Kristin Hendrickson, BA, RN, discuss phase 0 trials and how they can help expedite the research process for brain cancer therapies.

yellow background with a white outline indicating a brain

Dordaviprone Seeks FDA Approval for Recurrent H3K27M+ Diffuse Glioma

Chris Ryan
January 5th 2025
Article

A new drug application has been submitted to the FDA for dordaviprone to treat recurrent H3K27M-mutant diffuse glioma.

FDA on blue background

Virus Therapy Gets Orphan Drug Designation for Glioma Treatment

Ryan Scott
November 10th 2024
Article

The FDA granted an orphan drug designation to herpes simplex virus type 1 (HSV-1) oncolytic virus MB-108 for malignant glioma treatment.

FDA Approves Ion Torrent Oncomine Dx Target for Brain Cancer

FDA Approves Ion Torrent Oncomine Dx Target for Brain Cancer

Caroline Seymour
October 21st 2024
Article

The FDA approved a companion diagnostic for vorasidenib for patients with grade 2 astrocytoma or oligodendroglioma.

drawing of a brain on yellow background

MTX110 May Improve Survival in Glioblastoma

Russ Conroy
October 21st 2024
Article

An investigational formula of panobinostat called MTX110 may improve outcomes in patients with recurrent glioblastoma.